How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Close this folder8 EVALUATION
View the documentEvaluation of the NF within the framework of existing monitoring and evaluation activities
View the documentHow to design the evaluation
Close this folderWhat to evaluate
View the documentPolicy, legal framework and management support
View the documentSelection
View the documentProcurement
View the documentDistribution of formulary
View the documentRational use
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Policy, legal framework and management support

Indicators

1. Are there any policies or legal requirements relevant to the production, distribution and use of the NF at the national or regional or health facility level? Yes/No

2. Is there continuing financial and human resource support from government or sponsors for production and implementation of the NF? Yes/No

3. Is there a fair representation of all professionals on the NFC? For example, does the committee have a minimum of seven members representing the medical, nursing, pharmacy and laboratory health professions. Yes/No

4. Is the coverage of the formulary adequate? Yes/No

Coverage is calculated as:

The ideal figure is close to or above 100%; if too few copies have been printed this will limit impact.

5. Are NF activities linked with other programme activities promoting the rational use of medicines, e.g. production of clinical guidelines, basic and continuing education of health professionals, activities of the drug and therapeutics committee? Yes/No

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014